Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice

被引:85
|
作者
Persson, L
Borén, J
Robertson, AKL
Wallenius, V
Hansson, GK
Pekna, M
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem, S-40530 Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab Cardiovasc Res, S-40530 Gothenburg, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Res Ctr Endocrinol & Metab, S-40530 Gothenburg, Sweden
[4] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden
关键词
atherosclerosis; complement; C3; factor B; hyperlipidemia;
D O I
10.1161/01.ATV.0000127302.24266.40
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - To investigate the effect of complement deficiency on atherogenesis and lipidemia, we used mice deficient in the third complement component (C3-/-) or factor B (FB-/-). Methods and Results - Complement-deficient mice were crossed with mice deficient in both apolipoprotein E and the low-density lipoprotein receptor (Apoe-/- LDLR-/-). The percent lesion area in the aorta at 16 weeks, determined by en face analysis, was 84% higher in C3-/- mice than in controls (11.8% +/- 0.4% versus 6.4% +/- 0.8%, mean +/- SEM, P < 0.00005). The C3-/- mice also had 58% higher serum triglyceride levels (P < 0.05) and a more proatherogenic lipoprotein profile, with significantly more low-density lipoprotein cholesterol and very-low-density lipoprotein triglycerides than control mice. The C3-/- mice weighed 13% less (P < 0.01) and had a lower body fat content (3.5% +/- 1.0% versus 13.1% +/- 3.0%, P < 0.01). There were no differences between FB-/- mice and controls. Conclusions - Complement activation by the classical or lectin pathway exerts atheroprotective effects, possibly through the regulation of lipid metabolism.
引用
收藏
页码:1062 / 1067
页数:6
相关论文
共 50 条
  • [21] Liver-specific inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice
    Bell, Thomas A., III
    Brown, J. Mark
    Graham, Mark J.
    Lemonidis, Kristina A.
    Crooke, Rosanne M.
    Rudel, Lawrence L.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (08) : 1814 - 1820
  • [22] Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions
    Cyrus, T
    Yao, YM
    Rokach, J
    Tang, LX
    Praticò, D
    CIRCULATION, 2003, 107 (04) : 521 - 523
  • [23] Overexpression of Tissue Inhibitor of Metalloproteinase 3 in Macrophages Reduces Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice
    Casagrande, Viviana
    Menghini, Rossella
    Menini, Stefano
    Marino, Arianna
    Marchetti, Valentina
    Cavalera, Michele
    Fabrizi, Marta
    Hribal, Marta L.
    Pugliese, Giuseppe
    Gentileschi, Paolo
    Schillaci, Orazio
    Porzio, Ottavia
    Lauro, Davide
    Sbraccia, Paolo
    Lauro, Renato
    Federici, Massimo
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (01) : 74 - U190
  • [24] The Alternative Pathway Is Critical for Pathogenic Complement Activation in Endotoxin- and Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
    Malik, Talat H.
    Cortini, Andrea
    Carassiti, Daniele
    Boyle, Joseph J.
    Haskard, Dorian O.
    Botto, Marina
    CIRCULATION, 2010, 122 (19) : 1948 - U122
  • [25] Reduced progression of atherosclerosis in apolipoprotein E-deficient mice treated with lacidipine is associated with a decreased susceptibility of low-density lipoprotein to oxidation
    Cristofori, P
    Crivellente, F
    Campagnola, M
    Fratta Pasini, A
    Garbin, U
    Rigoni, A
    Tosetti, M
    Turton, J
    Faustinelli, I
    Cominacini, L
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2004, 85 (02) : 105 - 114
  • [26] Alcohol feeding impedes early atherosclerosis in low-density lipoprotein receptor knockout mice: Factors in addition to high-density lipoprotein-apolipoprotein A1 are involved
    Dai, JN
    Miller, BA
    Lin, RC
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1997, 21 (01) : 11 - 18
  • [27] Dietary α-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice
    Zhang, Wei-Jian
    Bird, Karyn E.
    McMillen, Timothy S.
    LeBoeuf, Renee C.
    Hagen, Tory M.
    Frei, Balz
    CIRCULATION, 2008, 117 (03) : 421 - 428
  • [28] Brief report: Accelerated atherosclerosis in low-density lipoprotein receptor-deficient mice lacking the membrane-bound complement regulator CD59
    Yun, Sheng
    Leung, Viola W. Y.
    Botto, Marina
    Boyle, Joseph J.
    Haskard, Dorian O.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (10) : 1714 - 1716
  • [29] Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice
    Babaev, Vladimir R.
    Yeung, Michele
    Erbay, Ebru
    Ding, Lei
    Zhang, Youmin
    May, James M.
    Fazio, Sergio
    Hotamisligil, Gokhan S.
    Linton, MacRae F.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (06) : 1122 - +
  • [30] Myeloid-Specific IκB Kinase β Deficiency Decreases Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
    Park, Se-Hyung
    Sui, Yipeng
    Gizard, Florence
    Xu, Jinxian
    Rios-Pilier, Jennifer
    Helsley, Robert N.
    Han, Seong-Su
    Zhou, Changcheng
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (12) : 2869 - +